Pharmaceutical companies' policies on access to trial data, results, and methods: audit study.
<h4>Objectives</h4> <p>To identify the policies of major pharmaceutical companies on transparency of trials, to extract structured data detailing each companies’ commitments, and to assess concordance with ethical and professional guidance.</p> <h4>Design</h4> &l...
Main Authors: | Goldacre, B, Lane, S, Mahtani, K, Heneghan, C, Onakpoya, I, Bushfield, I, Smeeth, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2017
|
Similar Items
-
Improving, and auditing, access to clinical trial results.
by: Goldacre, B, et al.
Published: (2014) -
Noncommercial funders' policies on trial registration, access to summary results, and individual patient data availability
by: DeVito, NJ, et al.
Published: (2018) -
Availability of results of clinical trials registered on EU Clinical Trials Register: cross sectional audit study
by: DeVito, NJ, et al.
Published: (2024) -
Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.
by: Heneghan, C, et al.
Published: (2017) -
Access to Pharmaceuticals: An Overview
by: Ang, Wei Chern, et al.
Published: (2022)